Thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), ERCC1, & thymidine phosphorylase gene expression in primary & metastatic (met) colorectal cancer (CRC) tissue in patients (pts) treated on a phase I trial of oxaliplatin (OX) & capecitabine (Xel)

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 3549-3549 ◽  
Author(s):  
J. L. Grem ◽  
K. Uchida ◽  
D. Salonga ◽  
P. Danenberg ◽  
K. Danenberg
Keyword(s):  
Gene Expression ◽  
Colorectal Cancer ◽  
Phase I ◽  
Thymidylate Synthase ◽  
Thymidine Phosphorylase ◽  
Phase I Trial ◽  
Dihydropyrimidine Dehydrogenase

Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients

2006 ◽  
Vol 16 (11) ◽  
pp. 809-816 ◽  
Author(s):  
Federica Amatori ◽  
Antonello Di Paolo ◽  
Mario Del Tacca ◽  
Gabriella Fontanini ◽  
Francesca Vannozzi ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Thymidylate Synthase ◽  
Thymidine Phosphorylase ◽  
Dihydropyrimidine Dehydrogenase ◽  
Normal Mucosa ◽  
Thymidine Phosphorylase Expression

scholarly journals A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan

2018 ◽  
Vol 24 (24) ◽  
pp. 6160-6167 ◽  
Author(s):  
Valerie Lee ◽  
Judy Wang ◽  
Marianna Zahurak ◽  
Elske Gootjes ◽  
Henk M. Verheul ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase I ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Phase I Trial ◽  
Colorectal Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document